GlucoTrack, Inc. (GCTK)

Market Cap	4.12M
Revenue (ttm)	n/a
Net Income (ttm)	-26.50M
Shares Out	28.64M
EPS (ttm)	-9.44
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,357,464
Open	0.1400
Previous Close	0.1374
Day's Range	0.1360 - 0.1475
52-Week Range	0.1231 - 62.6000
Beta	-0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 17, 2025

About GCTK

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2001
• Employees: 11
• Stock Exchange: NASDAQ
• Ticker Symbol: GCTK
• Website: https://glucotrack.com